These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27395403)

  • 61. Evaluation of the Expression Profile of Extrapyramidal Symptoms Due to Antipsychotics by Data Mining of Japanese Adverse Drug Event Report (JADER) Database.
    Kose E; Uno K; Hayashi H
    Yakugaku Zasshi; 2017; 137(1):111-120. PubMed ID: 28049887
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole.
    Selfani K; Soland VL; Chouinard S; Huot P
    Neurologist; 2017 Jan; 22(1):24-28. PubMed ID: 28009769
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Efficacy and safety of paliperidone extended release in adolescents with schizophrenia: a randomized, double-blind study.
    Savitz AJ; Lane R; Nuamah I; Gopal S; Hough D
    J Am Acad Child Adolesc Psychiatry; 2015 Feb; 54(2):126-137.e1. PubMed ID: 25617253
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder: Part 1.
    Preskorn S; Flynn A; Macaluso M
    J Psychiatr Pract; 2015 Sep; 21(5):359-69. PubMed ID: 26348804
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Long-Term Improvement and Safety of Aripiprazole for Irritability and Adaptive Function in Asian Children and Adolescents with Autistic Disorder: A 52-Week, Multinational, Multicenter, Open-Label Study.
    Kim BU; Kim HW; Park EJ; Kim JH; Boon-Yasidhi V; Tarugsa J; Reyes A; Manalo SG; Joung YS
    J Child Adolesc Psychopharmacol; 2022 Sep; 32(7):390-399. PubMed ID: 36112116
    [No Abstract]   [Full Text] [Related]  

  • 66. Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six-month results from the European schizophrenia outpatient health outcomes study.
    Novick D; Haro JM; Bertsch J; Haddad PM
    J Clin Psychopharmacol; 2010 Oct; 30(5):531-40. PubMed ID: 20814320
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia.
    Barnes TR; McPhillips MA
    Int Clin Psychopharmacol; 1998 Mar; 13 Suppl 3():S49-57. PubMed ID: 9690971
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Aripiprazole: a review of its use in the treatment of manic episodes in adolescents with bipolar I disorder.
    McKeage K
    CNS Drugs; 2014 Feb; 28(2):171-83. PubMed ID: 24399490
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The factor structure of extrapyramidal symptoms evaluated using the Drug-Induced Extrapyramidal Symptoms Scale in patients with schizophrenia: Results from the 2016 REAP AP-4 study.
    Kubota C; Inada T; Lin SK; Avasthi A; Chee KY; Tanra AJ; Yang SY; Chen LY; Chong MY; Tripathi A; Kallivayalil RA; Grover S; Park SC; Kato TA; Xiang YT; Sim K; Maramis MM; Noor IM; Tan CH; Sartorius N; Shinfuku N
    Hum Psychopharmacol; 2023 Mar; 38(2):e2861. PubMed ID: 36462184
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Acute extrapyramidal syndromes in neuroleptic-treated elders: a pilot study.
    Ganzini L; Heintz R; Hoffman WF; Keepers GA; Casey DE
    J Geriatr Psychiatry Neurol; 1991; 4(4):222-5. PubMed ID: 1686396
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Neuroleptic side effects: acute extrapyramidal syndromes and tardive dyskinesia.
    Casey DE; Keepers GA
    Psychopharmacol Ser; 1988; 5():74-93. PubMed ID: 2901085
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis.
    Cohen D; Bonnot O; Bodeau N; Consoli A; Laurent C
    J Clin Psychopharmacol; 2012 Jun; 32(3):309-16. PubMed ID: 22544019
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole.
    Jakobsen KD; Bruhn CH; Pagsberg AK; Fink-Jensen A; Nielsen J
    J Clin Psychopharmacol; 2016 Oct; 36(5):496-9. PubMed ID: 27504593
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Physical Health Outcomes in Preschoolers with Prior Authorization for Antipsychotics.
    Wei YJ; Liu X; Rao N; McPherson M; Jones MB; Bussing R; Winterstein AG
    J Child Adolesc Psychopharmacol; 2017 Nov; 27(9):833-839. PubMed ID: 28708433
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effects of newer antipsychotics on extrapyramidal function.
    Tarsy D; Baldessarini RJ; Tarazi FI
    CNS Drugs; 2002; 16(1):23-45. PubMed ID: 11772117
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms.
    Timdahl K; Carlsson A; Stening G
    Hum Psychopharmacol; 2007 Jul; 22(5):315-25. PubMed ID: 17542047
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sorting through EPS (extrapyramidal symptoms).
    Blair DT
    Geriatr Nurs; 1991; 12(5):244-6. PubMed ID: 1687319
    [No Abstract]   [Full Text] [Related]  

  • 78. Effects and Dose-Response Relationship of Balance Training on Balance Performance in Youth: A Systematic Review and Meta-Analysis.
    Gebel A; Lesinski M; Behm DG; Granacher U
    Sports Med; 2018 Sep; 48(9):2067-2089. PubMed ID: 29736728
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Relationship of extrapyramidal symptoms to age at onset and drug treatment in middle-aged and elderly schizophrenic patients.
    Srinivasan TN; Thara R; Padmavathi R; McCreadie RG
    Schizophr Res; 2001 Jan; 47(1):69-75. PubMed ID: 11163546
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.